Greenyn Biotechnology Co Ltd

ROCO:6846 (Taiwan)  
NT$ 80.00 (+5.54%) Jun 5
15.10
P/B:
2.88
Market Cap:
NT$ 2.15B ($ 66.58M)
Enterprise V:
NT$ 1.84B ($ 56.97M)
Volume:
18.00K
Avg Vol (2M):
22.02K
Volume:
18.00K
Avg Vol (2M):
22.02K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Greenyn Biotechnology Co Ltd ( ROCO:6846 ) from 2022 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Greenyn Biotechnology stock (ROCO:6846) PE ratio as of Jun 06 2024 is 15.1. More Details

Greenyn Biotechnology Co Ltd (ROCO:6846) PE Ratio (TTM) Chart

To

Greenyn Biotechnology Co Ltd (ROCO:6846) PE Ratio (TTM) Historical Data

Total 522
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Greenyn Biotechnology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-06 15.1 2024-04-01 15.1
2024-06-05 15.1 2024-03-29 15.1
2024-06-04 14.3 2024-03-28 15.2
2024-06-03 14.3 2024-03-27 16.0
2024-05-31 14.4 2024-03-26 16.1
2024-05-30 14.5 2024-03-25 16.1
2024-05-29 14.4 2024-03-22 15.9
2024-05-28 14.4 2024-03-21 16.1
2024-05-27 14.4 2024-03-20 16.0
2024-05-24 15.1 2024-03-19 16.2
2024-05-23 15.1 2024-03-18 16.6
2024-05-22 14.9 2024-03-15 16.2
2024-05-21 15.0 2024-03-14 15.9
2024-05-20 14.8 2024-03-13 15.9
2024-05-17 14.8 2024-03-12 15.9
2024-05-16 14.8 2024-03-11 15.8
2024-05-15 14.9 2024-03-08 15.8
2024-05-14 14.5 2024-03-07 15.9
2024-05-13 14.4 2024-03-06 16.0
2024-05-10 15.1 2024-03-05 16.0
2024-05-09 15.0 2024-03-04 15.7
2024-05-08 15.0 2024-03-01 15.8
2024-05-07 14.8 2024-02-29 16.0
2024-05-06 14.9 2024-02-27 16.1
2024-05-03 14.8 2024-02-26 15.8
2024-05-02 14.7 2024-02-23 16.0
2024-04-30 14.7 2024-02-22 16.0
2024-04-29 14.7 2024-02-21 15.9
2024-04-26 14.8 2024-02-20 16.0
2024-04-25 14.8 2024-02-19 16.0
2024-04-24 15.0 2024-02-16 15.7
2024-04-23 14.8 2024-02-15 15.7
2024-04-22 14.4 2024-02-05 15.1
2024-04-19 14.7 2024-02-02 15.1
2024-04-18 16.3 2024-02-01 15.2
2024-04-17 14.8 2024-01-31 15.4
2024-04-16 14.7 2024-01-30 15.2
2024-04-15 14.8 2024-01-29 15.2
2024-04-12 15.1 2024-01-26 15.2
2024-04-11 15.1 2024-01-25 15.2
2024-04-10 15.1 2024-01-24 15.3
2024-04-09 15.2 2024-01-23 15.4
2024-04-08 15.1 2024-01-22 15.4
2024-04-03 15.1 2024-01-19 15.5
2024-04-02 15.1 2024-01-18 15.2

Greenyn Biotechnology Co Ltd (ROCO:6846) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.